Abstract
Optimal care of patients with head and neck squamous cell cancer (HNSCC) involves a pre-determined period of post-treatment follow-up for the detection of recurrent or persistent disease, metastases and second primaries at the earliest opportunity. There is little evidence in literature as to whether the surveillance schemes should be based on patient survival, quality of life or cost-adjusted parameters. This article aims at highlighting some of the issues pertinent to the optimization of surveillance strategies in HNSCC.
This is a preview of subscription content, log in via an institution to check access.
References
Ridge JA (1993) Squamous cancer of the head and neck: surgical treatment of local and regional recurrence. Semin Oncol 20:419–429
DeVisscher AVM, Manni JJ (1994) Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Arch Otolaryngol Head Neck Surg 120:934–939
Loree TR (1997) Head and neck carcinoma: counterpoint. In: Johnson FE, Virgo KS (eds) Cancer patient follow-up. Mosby–Year Book Inc, St. Louis, p 72.13
Coniglio JU, Netterville JL (1993) Guidelines for patient management. In: Bailey BJ, Johnson JT, Pillsbury HC, Kohut RI, Tardy ME Jr (eds) Head and neck surgery otolaryngology. JB Lippincott, Philadelphia, pp 1021–1028
Clinical Practice Guidelines Task Force (1996) Clinical practice guidelines for the diagnosis and management of cancer of the head and neck. The American Society for Head and Neck Surgery, Pittsburgh, PA, Society of Head and Neck Surgeons, Arlington, VA
British Association of Head and Neck Oncologists (2001) Practice care guidance for clinicians participating in the management of head and neck cancer patients in the UK. Drawn up by a Consensus Group of Practising Clinicians. Eur J Surg Oncol 27(Suppl A):S1–S17
Boysen M, Lövdal O, Tausjö J, Winther F (1992) The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer 28:426–430
Schwartz DL, Barker J Jr, Chansky K et al (2003) Postradiotherapy surveillance practice for head and neck squamous cell carcinoma–too much or too little? Head Neck 25:990–999
Johnson FE, Johnson MH, Clemente MF, Paniello RC, Virgo KS (2006) Geographical variation in surveillance strategies after curative-intent surgery for upper aerodigestive tract cancer. Ann Surg Oncol 13:1063–1071
Mukherji SK, Mancuso AA, Kotzur IM et al (1994) Radiologic appearance of the irradiated larynx. Part II. Primary site response. Radiology 193:149–154
O’Meara WP, Thiringer JK, Johnstone PA (2003) Follow-up of head and neck cancer patients post-radiotherapy. Radiother Oncol 66:323–326
Schoder H, Yeung HWD, Gonen M et al (2004) Head and neck cancer: clinical usefulness and accuracy of PET/CT image fusion. Radiology 231:65–72
Abgral R, Querellou S, Potard G et al (2009) Does 18F-FDG PET/CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up? J Nucl Med 50:24–29
Haughey BH, Gates GA, Arfken CL, Harvey J (1992) Meta-analysis of second malignant tumors in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhinol Laryngol 101:105–112
Cetinayak O, Akman F, Kentli S et al (2008) Assessment of treatment-related thyroid dysfunction in patients with head and neck cancer. Tumori 94:19–23
Virgo KS, Paniello RC, Johnson FE (1998) Costs of posttreatment surveillance for patients with upper aerodigestive tract cancer. Arch Otolaryngol Head Neck Surg 124:564–572
Conflict of interest
None to declare.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kazi, R., Manikanthan, K., Pathak, K.A. et al. Head and neck squamous cell cancers: need for an organised time-bound surveillance plan. Eur Arch Otorhinolaryngol 267, 1969–1971 (2010). https://doi.org/10.1007/s00405-010-1377-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00405-010-1377-x